A gel electrophoresis assay for the simultaneous determination of topoisomerase I inhibition and DNA intercalation.
The DNA maintenance enzyme, topoisomerase I, is thought to play crucial roles in all living cells and for this reason inhibitors of this enzyme have been much studied. In this paper we describe a gel electrophoresis method capable of characterizing and quantifying inhibition of topoisomerase I by selected compounds. Inhibitors of topoisomerase I are often associated with intercalative binding to DNA and the method can simultaneously determine intercalative binding (as DNA unwinding) except in the cases where inhibition is prohibitively strong. The method uses closed circular (plasmid) DNA and can separate single-strand nicked, linearized (double-strand nicked), fully relaxed, partially relaxed (topoisomers), and supercoiled forms of the plasmid so that topoisomerase-dependent DNA cleavage (poisoning) can also be determined. By quantifying poisoning, inhibition, and intercalation simultaneously and separately in relation to reference compounds it is possible to make quantitative determinations of these phenomena for comparative purposes. Data for the topoisomerase I inhibitor, luteolin, are presented.
Webb
Michael R
MR
Department of Viticulture and Enology, University of California-Davis, 1 Shields Ave, Davis, CA 95616, USA.
Ebeler
Susan E
SE
D002166:Camptothecin / Q000494:pharmacology; D004264:DNA Topoisomerases, Type I / Q000378:metabolism; D004278:DNA, Superhelical / Q000737:chemistry* / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004587:Electrophoresis, Agar Gel / Q000379:methods*; D004996:Ethidium / Q000494:pharmacology; D005419:Flavonoids / Q000494:pharmacology; D007364:Intercalating Agents / Q000494:pharmacology*; D044949:Kaempferols / Q000494:pharmacology; D047311:Luteolin; D009690:Nucleic Acid Conformation / Q000187:drug effects; D010957:Plasmids / Q000737:chemistry / Q000378:metabolism; D059004:Topoisomerase I Inhibitors
D004278:DNA, Superhelical; D005419:Flavonoids; D007364:Intercalating Agents; D044949:Kaempferols; D059004:Topoisomerase I Inhibitors; C006552:kaempferol; D004264:DNA Topoisomerases, Type I; D004996:Ethidium; D047311:Luteolin; D002166:Camptothecin